What are nucleosides used for?

Nucleosides are base molecules used as starting materials for synthesizing nucleotides and phosphoramidites.

What is the difference between nucleosides and nucleotides?

Nucleosides lack phosphate groups, while nucleotides contain one or more phosphates required for enzymatic reactions.

Are nucleosides used directly in enzymatic reactions?

Nucleosides are typically chemically modified before being used in enzymatic workflows.

Can nucleosides be chemically modified?

Yes, modified nucleosides are widely used to introduce structural or functional changes in nucleic acids.

Why is nucleoside purity important?

High purity ensures correct downstream synthesis of nucleotides and phosphoramidites with predictable performance.

Nucleosides - RNA / BOC Sciences

2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine

Description: 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine, a compound hailed within the biomedical industry, exhibiting intriguing medicinal potential. It serves as a catalyst in the creation of tailored therapeutics, meticulously designed to thwart precise pathways by selectively maneuvering functions.

CAT: BRP-01714

CAS: 869354-79-0

Molecular Formula: C39H45N7O7

Molecular Weight: 723.84

Purity: ≥97%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.29±0.1 g/cm3

InChIKey: HUYROJQAEKXGHQ-GONXPTGJSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OC)N=CN(C)C

IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-6-(dimethylaminomethylideneamino)purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C39H45N7O7/c1-24(2)36(48)44-38-42-34(41-22-45(3)4)31-35(43-38)46(23-40-31)37-33(51-7)32(47)30(53-37)21-52-39(25-11-9-8-10-12-25,26-13-17-28(49-5)18-14-26)27-15-19-29(50-6)20-16-27/h8-20,22-24,30,32-33,37,47H,21H2,1-7H3,(H,42,43,44,48)/t30-,32-,33-,37-/m1/s1

Synonyms: Adenosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-[(dimethylamino)methylene]-2'-O-methyl-2-[(2-methyl-1-oxopropyl)amino]-; N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-(((dimethylamino)methylene)amino)-9H-purin-2-yl)isobutyramide; 2'-OMe-5'-DMT-2,6-diamino purine riboside (n6,n6-dmf) (n2-ibu); 2'-OMe-5'-DMT-N2-amino-ibu rA(N6-DMF)

5'-O-DMT-N6-(2-phenoxyacetyl)-adenosine

Description: 5'-O-DMT-N6-(2-phenoxyacetyl)-adenosine, a biomedical marvel, takes the forefront in combating a myriad of ailments. Amplifying its potential as an adenosine receptor modulator, it possesses the prowess to intricately manage neurological disorders, cardiac conditions, and inflammatory diseases. Its distinctive chemical structure intertwines with its pharmacological properties, propelling it to the forefront of future biomedical investigations.

CAT: BRP-01715

CAS: 121076-16-2

Molecular Formula: C39H37N5O8

Molecular Weight: 703.74

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.36±0.1 g/cm3 (Predicted)

InChIKey: GWFRSQBGIGLMFD-BBKOCAQVSA-N

CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)NC(=O)COC7=CC=CC=C7)O)O

IUPAC Name: N-[9-[(2R,3R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3,4-dihydroxyoxolan-2-yl]purin-6-yl]-2-phenoxyacetamide

InChI: InChI=1S/C39H37N5O8/c1-48-28-17-13-26(14-18-28)39(25-9-5-3-6-10-25,27-15-19-29(49-2)20-16-27)51-21-31-34(46)35(47)38(52-31)44-24-42-33-36(40-23-41-37(33)44)43-32(45)22-50-30-11-7-4-8-12-30/h3-20,23-24,31,34-35,38,46-47H,21-22H2,1-2H3,(H,40,41,43,45)/t31-,34-,35-,38-/m1/s1

Synonyms: 5'-DMT Adenosine (n-PAC); 5'-O-(4,4'-Dimethoxytrityl)-N6-phenoxyacetyl adenosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-N6-(2-phenoxyacetyl)adenosine; N-(Phenoxyacetyl)-5'-O-(4,4'-dimethoxytrityl)adenosine; N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)-2-phenoxyacetamide; 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-N-(phenoxyacetyl)adenosine

7-Deazainosine

Description: 7-Deazainosine is a modified nucleoside derivative that is used in RNA and DNA research. It is a modified form of adenosine where the nitrogen at the 7-position of the purine ring is replaced by a carbon atom. This modification alters the base-pairing properties of the nucleoside, making it useful for studying RNA folding and interactions. Additionally, 7-Deazainosine can also be incorporated into synthetic oligonucleotides for various applications in molecular biology and biotechnology.

CAT: BRP-01717

CAS: 2862-16-0

Molecular Formula: C11H13N3O5

Molecular Weight: 267.24

Purity: 95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.90±0.1 g/cm3

Melting Point: 240 °C

Boiling Point: 679.7±55.0 °C at 760 mmHg

InChIKey: DPRSKJHWKNHBOW-KCGFPETGSA-N

CanonicalSMILES: C1=CN(C2=C1C(=O)NC=N2)C3C(C(C(O3)CO)O)O

IUPAC Name: 7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one

InChI: InChI=1S/C11H13N3O5/c15-3-6-7(16)8(17)11(19-6)14-2-1-5-9(14)12-4-13-10(5)18/h1-2,4,6-8,11,15-17H,3H2,(H,12,13,18)/t6-,7-,8-,11-/m1/s1

Synonyms: 7-Deaza ribo Inosine; 3,7-Dihydro-7-β-D-ribofuranosyl-4H-pyrrolo[2,3-d]pyrimidin-4-one; 4H-Pyrrolo[2,3-d]pyrimidin-4-one, 1,7-dihydro-7-β-D-ribofuranosyl-; 7-(β-D-Ribofuranosyl)pyrrolo[2,3-d]pyrimidin-4-one; 7-β-D-Ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol; Antibiotic XK 101-2; NSC 99439

7-Deazaguanosine

Description: It is a guanosine analogue with antiviral and anti-HCV activity.

CAT: BRP-01718

CAS: 62160-23-0

Molecular Formula: C11H14N4O5

Molecular Weight: 282.25

Purity: ≥95%

Appearance: Off-white Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C under inert atmosphere

Density: 2.06±0.1 g/cm3 (Predicted)

Melting Point: >250°C (dec.)

Boiling Point: 668.3±65.0°C at 760 mmHg

InChIKey: JRYMOPZHXMVHTA-DAGMQNCNSA-N

Solubility: Soluble in Methanol

CanonicalSMILES: C1=CN(C2=C1C(=O)NC(=N2)N)C3C(C(C(O3)CO)O)O

IUPAC Name: 2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one

InChI: InChI=1S/C11H14N4O5/c12-11-13-8-4(9(19)14-11)1-2-15(8)10-7(18)6(17)5(3-16)20-10/h1-2,5-7,10,16-18H,3H2,(H3,12,13,14,19)/t5-,6-,7-,10-/m1/s1

Synonyms: 7-Deaza ribo Guanosine; 2-Amino-7-(β-D-ribofuranosyl)-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one; 2-Amino-1,7-dihydro-7-β-D-ribofuranosyl-4H-pyrrolo[2,3-d]pyrimidin-4-one; 2-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one; N7-Deazaguanosine

β-L-Adenosine

Description: β-L-Adenosine is a versatile biochemical compound extensively employed in the biomedical sector for advanced research studies, showcasing a profound significance in probing its exceptional efficacy against a gamut of ailments, including cancer, viral infections, as well as autoimmune disorders.

CAT: BRP-01727

CAS: 3080-29-3

Molecular Formula: C10H13N5O4

Molecular Weight: 267.24

Purity: ≥97% by HPLC

Appearance: White Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 2.08±0.1 g/cm3 (Predicted)

Melting Point: 219-224°C

Boiling Point: 676.3±65.0°C (Predicted)

InChIKey: OIRDTQYFTABQOQ-DEGSGYPDSA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Heated)

CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N

IUPAC Name: (2S,3S,4R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m0/s1

Synonyms: Beta-L-ribo Adenosine; L-Adenosine; L-rA; Beta-L-adenosine; (2S,3S,4R,5S)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 9-beta-L-Ribofuranosyladenine; 9-(b-L-Ribofuranosyl)adenine; 9-beta-L-Ribofuranosyl-9H-purine-6-amine

L-Cytidine

Description: L-Cytidine is a prominent bioactive compound employed extensively, emerging as a pivotal compound for the genesis of nucleic acids. Exerting a profound influence on cellular metabolism, it assumes a crucial mantle in studying diverse ailments encompassing viral afflictions, malignant neoplasms and conditions affecting the neurologic milieu.

CAT: BRP-01728

CAS: 26524-60-7

Molecular Formula: C9H13N3O5

Molecular Weight: 243.22

Purity: ≥97% by HPLC

Appearance: White to Off-white Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.89±0.1 g/cm3

Boiling Point: 545.7±60.0 °C at 760 mmHg

InChIKey: UHDGCWIWMRVCDJ-PSQAKQOGSA-N

CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O

IUPAC Name: 4-amino-1-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

InChI: InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m0/s1

Synonyms: Beta-L-ribo Cytidine; beta-L-Cytidine; 4-Amino-1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 1-beta-L-Ribofuranosylcytosine; L-rC; 2(1H)-Pyrimidinone, 4-amino-1-beta-L-ribofuranosyl-; 4-Amino-1-(β-L-ribofuranosyl)-2(1H)-pyrimidinone; β-L-Cytidine

L-Uridine

Description: L-Uridine, a crucial nucleoside component harnessed for its role in promoting protein synthesis, boasts neuroprotective abilities, demonstrated in its function as a potent inhibitor of neuronal death while concurrently elevating neuroplasticity. Exhibiting efficacy in treating neurodegenerative ailments such as Alzheimer's and Parkinson's disease, L-Uridine further improves cognitive functions and memory. Its diverse range extends to addressing certain types of cancer and viral infections, positioning it to be a burgeoning therapeutic marvel.

CAT: BRP-01730

CAS: 26287-69-4

Molecular Formula: C9H12N2O6

Molecular Weight: 244.20

Purity: ≥99% by HPLC

Appearance: White to off-white crystalline powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.674±0.06 g/cm3

InChIKey: DRTQHJPVMGBUCF-PSQAKQOGSA-N

CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O

IUPAC Name: 1-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m0/s1

Synonyms: Beta-L-ribo Uridine; 1-(b-L-ribofuranosyl)uracil; 1-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-β-L-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione; Uracil, 1-β-L-ribofuranosyl-; β-L-Uridine

L-Inosine

Description: L-Inosine is a pivotal nucleoside, showcasing indispensible involvement in energy metabolism and purine nucleotide synthesis. Its profound significance thrives in the biomedical sector, where it acts as a adjunct for studying multifarious ailments such as immune-related disorders, neurodegenerative afflictions and cardiovascular maladies.

CAT: BRP-01731

CAS: 21138-24-9

Molecular Formula: C10H12N4O5

Molecular Weight: 268.23

Purity: ≥97% by HPLC

Appearance: Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 2.08 g/cm3

Melting Point: 218 °C

Boiling Point: 797.9±60.0 °C(Predicted)

InChIKey: UGQMRVRMYYASKQ-DEGSGYPDSA-N

CanonicalSMILES: C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O

IUPAC Name: 9-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

InChI: InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m0/s1

Synonyms: Beta-L-ribo Inosine; 9-((2S,3S,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one; 9-beta-L-Ribofuranosylhypoxanthine; L-ribofuranosyl-Inosine; 1,9-Dihydro-9-β-L-ribofuranosyl-6H-purin-6-one; Hypoxanthine, 9-β-L-ribofuranosyl-; 9-(β-L-Ribofuranosyl)-3,9-dihydro-6H-purin-6-one; β-L-Inosine

1,N6-Ethenoadenosine

Description: N6-Ethenoadenosine, a purine nucleoside analog, is paramount for the examination of oxidative damage on cellular DNA. It has demonstrated a capability to initiate DNA damage and apoptosis in cancer cells, rendering it an integral component of investigating its effectiveness as an anticancer agent. Its potential usage within the realm of cancer treatment necessitates a thorough understanding and exploration of its capabilities.

CAT: BRP-01732

CAS: 39007-51-7

Molecular Formula: C12H13N5O4

Molecular Weight: 291.26

Purity: ≥95% by HPLC

Appearance: White to Brown Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 1.99±0.1 g/cm3

InChIKey: LRPBXXZUPUBCAP-WOUKDFQISA-N

CanonicalSMILES: C1=CN2C=NC3=C(C2=N1)N=CN3C4C(C(C(O4)CO)O)O

IUPAC Name: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-imidazo[2,1-f]purin-3-yloxolane-3,4-diol

InChI: InChI=1S/C12H13N5O4/c18-3-6-8(19)9(20)12(21-6)17-5-14-7-10-13-1-2-16(10)4-15-11(7)17/h1-2,4-6,8-9,12,18-20H,3H2/t6-,8-,9-,12-/m1/s1

Synonyms: Etheno ribo Adenosine; N6-Etheno-D-adenosine; N6-Ethenoadenosine; 3-(β-D-Ribofuranosyl)-3H-imidazo[2,1-i]purine; (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(3H-imidazo[2,1-i]purin-3-yl)tetrahydrofuran-3,4-diol; 3-β-D-Ribofuranosyl-3H-imidazo[2,1-i]purine; 1,6-Ethenoadenosine; Ethenoadenosine; N6-β-D-Ribosyl-1,N6-ethenoadenine; ε-Adenosine

N4-Ethenocytidine

Description: N4-Ethenocytidine, an indispensable compound within the biomedical industry, is of paramount significance. Its idiosyncratic molecular architecture renders it an ideal candidate for comprehensive research endeavors focusing on elucidating the intricate mechanisms underlying DNA methyltransferases' regulation and functionality. Profound insights gained from such investigations facilitate a holistic comprehension of the fundamental aspects of epigenetic modifications.

CAT: BRP-01733

CAS: 39007-52-8

Molecular Formula: C11H13N3O5

Molecular Weight: 267.24

Purity: ≥98% by HPLC

Appearance: White to off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.82±0.1 g/cm3

Boiling Point: 657.4±65.0 °C at 760 mmHg

InChIKey: DUCZQUFMCSTEHH-PEBGCTIMSA-N

CanonicalSMILES: C1=CN(C(=O)N2C1=NC=C2)C3C(C(C(O3)CO)O)O

IUPAC Name: 6-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazo[1,2-c]pyrimidin-5-one

InChI: InChI=1S/C11H13N3O5/c15-5-6-8(16)9(17)10(19-6)14-3-1-7-12-2-4-13(7)11(14)18/h1-4,6,8-10,15-17H,5H2/t6-,8-,9-,10-/m1/s1

Synonyms: Etheno ribo Cytidine; N4-Etheno-D-cytidine; Ethenocytidine; 6-β-D-Ribofuranosylimidazo[1,2-c]pyrimidin-5(6H)-one; 3,N4-Ethenocytidine

2,2'-Anhydrocytidine

Description: 2,2'-Anhydrocytidine, an intriguing compound highly regarded in the biomedical field, serves as a critical subject of research owing to its profound prospects in combatting viral infections, especially those instigated by RNA viruses.

CAT: BRP-01734

CAS: 31698-14-3

Molecular Formula: C9H11N3O4

Molecular Weight: 225.20

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Density: 2.01±0.1 g/cm3

Melting Point: 249 °C (dec.)

Boiling Point: 422.2±55.0 °C at 760 mmHg

InChIKey: BBDAGFIXKZCXAH-CCXZUQQUSA-N

Solubility: Soluble in Methanol (Slightly), Water (Sparingly)

CanonicalSMILES: C1=CN2C3C(C(C(O3)CO)O)OC2=NC1=N

IUPAC Name: (2R,4R,5R,6S)-4-(hydroxymethyl)-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-5-ol

InChI: InChI=1S/C9H11N3O4/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8/h1-2,4,6-8,10,13-14H,3H2/t4-,6-,7+,8-/m1/s1

Synonyms: Cytarabine Impurity H; (2R,3R,3aS,9aR)-2-(Hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol; 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R,3R,3aS,9aR)-; (2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-6-imino-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol; 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, [2R-(2α,3β,3aβ,9aβ)]-; 2,2'-Anhydro(1-β-D-arabinofuranosyl)cytosine; 2,2'-Anhydroarabinosylcytosine; 2,2'-Cyclocytidine; 2,2'-O-Cyclocytidine; Ancitabine; Ancytabine; Cyclocytidine; O2,2'-Cyclocytidine; O2:2'-Anhydro-1-β-D-arabinosylcytosine; Cytarabine EP Impurity H

Related CAS: 34939-46-3 (Deleted CAS) ; 36258-39-6 (Deleted CAS) ; 46488-37-3 (Deleted CAS) ; 51743-54-5 (Deleted CAS) ; 10212-25-6 (monohydrochloride)

2,2'-Cyclocytidine hydrochloride

Description: 2,2'-Anhydro-cytidine-HCl is a DNA synthesis inhibitor commonly used as an antineoplastic agent to treat leukemias.

CAT: BRP-01735

CAS: 10212-25-6

Molecular Formula: C9H12ClN3O4

Molecular Weight: 261.66

Purity: ≥95%

Appearance: White Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 2.01 g/cm3

Melting Point: >230°C (dec.)

Boiling Point: 442°C at 760 mmHg

Flash Point: 221.1°C

InChIKey: KZOWNALBTMILAP-JBMRGDGGSA-N

Solubility: Soluble in Methanol (Slightly), Water (Sparingly)

CanonicalSMILES: C1=CN2C3C(C(C(O3)CO)O)OC2=NC1=N.Cl

IUPAC Name: (2R,4R,5R,6S)-4-(hydroxymethyl)-10-imino-3,7-dioxa-1,9-diazatricyclo[6.4.0.02,6]dodeca-8,11-dien-5-ol;hydrochloride

InChI: InChI=1S/C9H11N3O4.ClH/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8;/h1-2,4,6-8,10,13-14H,3H2;1H/t4-,6-,7+,8-;/m1./s1

Synonyms: Ancytabine Hydrochloride; 2,2'-Anhydro-(1-β-D-arabinofuranosyl)cytosine hydrochloride; Cyclocytidine Hydrochloride; 2,2'-Anhydrocytarabine HCl; 2,2'-O-Cyclocytidine Hydrochloride; Cyclo-CMP Hydrochloride; NSC 145668; O2,O2'-Anhydro-1-β-D-arabinofuranosylcytosine Monohydrochloride; [2R-(2α,3β,3aβ,9aβ)]-2,3,3a,9a-Tetrahydro-3-hydroxy-6-imino-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol Monohydrochloride

Related CAS: 31698-14-3 (free base)

3-Methyluridine

Description: 3-Methyluridine is a modified nucleoside of RNA.

CAT: BRP-01736

CAS: 2140-69-4

Molecular Formula: C10H14N2O6

Molecular Weight: 258.23

Purity: ≥95%

Appearance: White Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 1.605±0.06 g/cm3 (Predicted)

Melting Point: 113-115°C

Boiling Point: 501.1±60.0°C (Predicted)

Application: 3-Methyluridine is a modified nucleoside of RNA.

Symbol: m³U

InChIKey: UTQUILVPBZEHTK-ZOQUXTDFSA-N

Solubility: Soluble in DMSO (Slightly, Heated), Methanol (Slightly, Heated), Water (Slightly, Sonicated)

CanonicalSMILES: CN1C(=O)C=CN(C1=O)C2C(C(C(O2)CO)O)O

IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methylpyrimidine-2,4-dione

InChI: InChI=1S/C10H14N2O6/c1-11-6(14)2-3-12(10(11)17)9-8(16)7(15)5(4-13)18-9/h2-3,5,7-9,13,15-16H,4H2,1H3/t5-,7-,8-,9-/m1/s1

Synonyms: N3-Methyl Uridine; N3-Methyluridine; N-3-Methyluridine; 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3-methylpyrimidine-2,4(1H,3H)-dione; NSC 246077; 3-Methyl-uridine; 3-Methyl-1-(β-L-ribofuranosyl)-2,4(1H,3H)-pyrimidinedione

N6-Phenoxyacetyladenosine

Description: N6-Phenoxyacetyladenosine is an extensively utilized compound in the biomedical sector, serving as a noteworthy resource for investigating adenosine receptors. This compound displays heightened affinity towards diverse subtypes of adenosine receptors due to its distinctive structural alteration.

CAT: BRP-01737

CAS: 119824-65-6

Molecular Formula: C18H19N5O6

Molecular Weight: 401.37

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.67±0.1 g/cm3

Melting Point: 110-112°C

InChIKey: FLHMVFSWPWAGQW-XKLVTHTNSA-N

Solubility: Soluble in Ethanol, Water

CanonicalSMILES: C1=CC=C(C=C1)OCC(=O)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O

IUPAC Name: N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-2-phenoxyacetamide

InChI: InChI=1S/C18H19N5O6/c24-6-11-14(26)15(27)18(29-11)23-9-21-13-16(19-8-20-17(13)23)22-12(25)7-28-10-4-2-1-3-5-10/h1-5,8-9,11,14-15,18,24,26-27H,6-7H2,(H,19,20,22,25)/t11-,14-,15-,18-/m1/s1

Synonyms: N6-PAc-rA; PAc-rA; N6-PAc-adenosine; ribo Adenosine (n-PAC); N-(Phenoxyacetyl)adenosine; N-(9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)-2-phenoxyacetamide; Adenosine, N-(2-phenoxyacetyl)-; N-(2-Phenoxyacetyl)adenosine

N4-Benzoyl-5-methylcytidine

Description: N4-Benzoyl-5-methylcytidine, an extraordinary biomedical compound, emerges as a pivotal player in combating diverse ailments. This remarkable agent manifests indispensible significance in precise drug or therapy delivery for cancer eradication, antiviral remedy, and genic treatment.

CAT: BRP-01738

CAS: 160107-15-3

Molecular Formula: C17H19N3O6

Molecular Weight: 361.35

Purity: 98%

Appearance: White to Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.55±0.1 g/cm3 (Predicted)

InChIKey: NVJJYVKITRVBHJ-BRXULGCHSA-N

Solubility: Soluble in Methanol

CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C(C(C(O3)CO)O)O

IUPAC Name: N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C17H19N3O6/c1-9-7-20(16-13(23)12(22)11(8-21)26-16)17(25)19-14(9)18-15(24)10-5-3-2-4-6-10/h2-7,11-13,16,21-23H,8H2,1H3,(H,18,19,24,25)/t11-,12-,13-,16-/m1/s1

Synonyms: 5-Methyl-cytidine (N-Bz); N4-Benzoyl-5-methyl-D-cytidine; N-Benzoyl-5-methylcytidine; N-(1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide

1-(6-Amino-9-β-D-ribofuranosyl-9H-purin-2-yl)-1H-pyrazole-4-carboxylic Acid Ethyl Ester

Description: A short-acting A2A adenosine receptor agonist.

CAT: BRP-01745

CAS: 313348-16-2

Molecular Formula: C16H19N7O6

Molecular Weight: 405.37

Purity: ≥98%

Appearance: Yellow Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.89±0.1 g/cm3

Boiling Point: 823.5±75.0 °C at 760 mmHg

InChIKey: ZPVLTIXYQGANFL-IDTAVKCVSA-N

Solubility: Soluble in Dimethyl Formamide

CanonicalSMILES: CCOC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N

IUPAC Name: ethyl 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]pyrazole-4-carboxylate

InChI: InChI=1S/C16H19N7O6/c1-2-28-15(27)7-3-19-23(4-7)16-20-12(17)9-13(21-16)22(6-18-9)14-11(26)10(25)8(5-24)29-14/h3-4,6,8,10-11,14,24-26H,2,5H2,1H3,(H2,17,20,21)/t8-,10-,11-,14-/m1/s1

Synonyms: 1H-Pyrazole-4-carboxylic acid, 1-(6-amino-9-β-D-ribofuranosyl-9H-purin-2-yl)-, ethyl ester; CVT 3127; CVT3127; CVT-3127; Regadenoson Impurity; Ethyl 1-(6-amino-9-β-D-ribofuranosyl-9H-purin-2-yl)-1H-pyrazole-4-carboxylate

5-Methoxycytidine

Description: 5-Methoxycytidine is an indispensable pharmaceutical compound, showcasing immense potential in the realm of disease research, especially cancer. Its significant ability to impede the expansion and multiplication of malignant cells substantiates its worth as an invaluable weapon in the ongoing research and development of anti-cancer drugs.

CAT: BRP-01758

CAS: 37805-90-6

Molecular Formula: C10H15N3O6

Molecular Weight: 273.24

Purity: ≥95%

Appearance: White to Off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.81±0.1 g/cm3 (Predicted)

Boiling Point: 569.9±60.0 °C at 760 mmHg

InChIKey: IZFJAICCKKWWNM-JXOAFFINSA-N

CanonicalSMILES: COC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O

IUPAC Name: 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methoxypyrimidin-2-one

InChI: InChI=1S/C10H15N3O6/c1-18-4-2-13(10(17)12-8(4)11)9-7(16)6(15)5(3-14)19-9/h2,5-7,9,14-16H,3H2,1H3,(H2,11,12,17)/t5-,6-,7-,9-/m1/s1

Synonyms: 5-Methoxy cytidine; 4-Amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methoxypyrimidin-2(1H)-one; NSC 339193; 5-OMe-Cr

N6-(4-Methyoxybenzoyl)adenosine

Description: N6-(4-Methoxybenzoyl)adenosine, a chemical compound, finds its essential use in investigating adenosine receptors in the domain of biomedicine, towards seeking cures for a diverse range of diseases. Its therapeutic potential is particularly noteworthy and extends to neurological conditions like Parkinson's disease and Alzheimer's disease, not to forget the noteworthy anti-inflammatory effects it has on cardiovascular diseases. The effective binding to adenosine receptors makes it fertile ground for exploring wider possibilities in the study of diseases.

CAT: BRP-01761

CAS: 56883-05-7

Molecular Formula: C18H19N5O6

Molecular Weight: 401.37

Purity: ≥97% by HPLC

Appearance: White to pale yellow solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 1.67±0.1 g/cm3 (Predicted)

InChIKey: YDVLBCYELIMFHS-XWXWGSFUSA-N

CanonicalSMILES: COC1=CC=C(C=C1)C(=O)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O

IUPAC Name: N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-4-methoxybenzamide

InChI: InChI=1S/C18H19N5O6/c1-28-10-4-2-9(3-5-10)17(27)22-15-12-16(20-7-19-15)23(8-21-12)18-14(26)13(25)11(6-24)29-18/h2-5,7-8,11,13-14,18,24-26H,6H2,1H3,(H,19,20,22,27)/t11-,13-,14-,18-/m1/s1

Synonyms: N6-Anisoyladenosine; Adenosine, N-(4-methoxybenzoyl)-; N-(p-Anisoyl)adenosine; N-(9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)-4-methoxybenzamide; N-(4-Methoxybenzoyl)adenosine; 6-N-p-Anisoyladenosine

N2-Phenoxyacetylguanosine

Description: N2-Phenoxyacetylguanosine, a renowned biomedical compound, garners attention due to its exceptional anti-viral qualities. Refined scientific research highlights its profound role as a potent inhibitor, effectively impeding the replication processes of select viruses through specific targeting of their viral enzymes. This exceptional product exhibits remarkable efficacy in combating viral infections triggered by distinct RNA viruses. Intriguingly, its mechanism of action disrupts viral RNA synthesis, presenting immense prospects for the development of avant-garde antiviral therapies.

CAT: BRP-01762

CAS: 119824-66-7

Molecular Formula: C18H19N5O7

Molecular Weight: 417.37

Purity: ≥95%

Appearance: White to Yellow Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.76±0.10 g/cm3

Melting Point: 159-160 °C

InChIKey: FOOYAXZEBFXEJD-IWCJZZDYSA-N

CanonicalSMILES: C1=CC=C(C=C1)OCC(=O)NC2=NC3=C(C(=O)N2)N=CN3C4C(C(C(O4)CO)O)O

IUPAC Name: N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-phenoxyacetamide

InChI: InChI=1S/C18H19N5O7/c24-6-10-13(26)14(27)17(30-10)23-8-19-12-15(23)21-18(22-16(12)28)20-11(25)7-29-9-4-2-1-3-5-9/h1-5,8,10,13-14,17,24,26-27H,6-7H2,(H2,20,21,22,25,28)/t10-,13-,14-,17-/m1/s1

Synonyms: Gua(pac); 2-N-phenoxyacetylguanosine; N-[9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl]-2-phenoxy-acetamide; N-(Phenoxyacetyl)guanosine; ribo Guanosine (n-PAC); N2-PAC-rG; N-(2-Phenoxyacetyl)guanosine

5'-O-DMTr-2'-O-(2-methoxyethyl)-uridine

Description: 5'-O-DMTr-2'-O-(2-methoxyethyl)-uridine, a compound widely employed in the realm of biomedicine, encapsulates vast prospects for therapeutic interventions in an array of ailments, encompassing viral infections and select malignancies. Possessing an idiosyncratic molecular configuration, this enigmatic substance has attained an eminent stance within drug exploration and advancement, particularly pertaining to nucleoside chemistry.

CAT: BRP-01763

CAS: 251647-51-5

Molecular Formula: C33H36N2O9

Molecular Weight: 604.65

Purity: ≥98% by HPLC

Appearance: White to Faint Yellow Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.34±0.1 g/cm3(Predicted)

InChIKey: YVYKKLNOXPCFGC-PMFUCWTESA-N

CanonicalSMILES: COCCOC1C(C(OC1N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O

IUPAC Name: 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C33H36N2O9/c1-39-19-20-42-30-29(37)27(44-31(30)35-18-17-28(36)34-32(35)38)21-43-33(22-7-5-4-6-8-22,23-9-13-25(40-2)14-10-23)24-11-15-26(41-3)16-12-24/h4-18,27,29-31,37H,19-21H2,1-3H3,(H,34,36,38)/t27-,29-,30-,31-/m1/s1

Synonyms: 5'-O-DMT-2'-O-(2-Methoxyethyl)-Uridine; 5'-O-(4,4'-Dimethoxytrityl)-2'-O-(2-methoxyethyl)uridine; 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)uridine; 5'-O-DMT-2'-O-MOE-Ur